Epidemiology of Viral Hepatitis from 2007 to 2016 in Karbala Governorate, Iraq.

Mohammed A Merzah, Ali Abd Al-Latif G Mohammed, Ali Neamah Hassan Al-Aaragi, Maytham Salim

Abstract read

In one paragraph

Article in Journal of research in health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Study of the D-dimer, C-reactive protein, and autoantibodies markers among HBV infected patients in Babylon province, Iraq.BioMedicine · 2021
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammed A MerzahLecturer at Department of Community Health, Technical Institute of Karbala, Al-Furat Al-Awsat Technical University- Kufa, Iraq. merzah.karbala@gmail.com.

Ali Abd Al-Latif G MohammedMaster of Community Health, Assistant Lecturer at the Department of Community Health, Technical Institute of Karbala, Al-Furat Al-Awsat Technical University- Kufa, Iraq.

Ali Neamah Hassan Al-AaragiMaster of Community Health, Assistant Lecturer at the Department of Community Health, Technical Institute of Karbala, Al-Furat Al-Awsat Technical University- Kufa, Iraq.

Maytham SalimLecturer at Department of Community Health, Technical Institute of Karbala, Al-Furat Al-Awsat Technical University- Kufa, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn escalation, as three times more, had been recognized in cases of hepatitis A (HAV) from 2009 to 2014 among Iraqi people. Regarding hepatitis B and C, Iraq is considered as a low endemic country comparing to neighbors. STUDY

designA retrospective cohort study.

methodsData incorporated from 2007 to 2016 were collected through a federal survey conducted by the Health Directorate of Karbala, who administrates all hospitals (three public hospitals and five private hospitals) and 40 health centers in Karbala City, Iraq. The four types of hepatitis and demographic information of all cases were included.

resultsA vivid shifting in the prevalence of HAV showed a decreasing pattern, that is, from 632 cases (PR=61) in 2007 to 314 cases (PR=33) in 2008. In 2012, its prevalence was twice greater (695 cases, PR=63.2). The PR of HBV also changed from 52 cases (PR=5.8) in 2007 to 26 cases (PR=2.8) in 2008. Regarding HCV, a decreasing pattern with 13 cases (PR=1.4) in 2007 and 12 cases (PR=1.2) in 2009 was seen. This number increased to 60 cases (PR=3.9) in 2016. For HEV, more cases were reported (47 cases, PR=4.7) in 2010.

conclusionThe four types of hepatitis have been highly prevalent since 2010. The high number of migrants to Karbala Governorate and unavailability of immunization might be reasons behind the high prevalence of the four-types of hepatitis.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHepacivirusHepatitis A virusHepatitis B virusHepatitis E virusHepatitis, Viral, HumanHumansImmunizationInfantIraqHepatitisIraqMigrantPrevalence

Identifiers

PMID31278219

PMCPMC7183541

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.